Xencor, Inc. · Monrovia, CA United States
Company Description
View Xencor, Inc. Locations On A US Map
This link will open in a new window
Don't come to Xencor if you need the hem adjusted on your new pants: The company tailors proteins, not pants. Xencor is developing therapeutics for cancer, inflammatory ailments, and autoimmune diseases. The company engineers antibodies using its Protein Design Automation (PDA) technology, which allows for the specific targeting of diseased cells. Its drug candidates aim to treat cancerous conditions such as Hodgkin's lymphoma, T-cell lymphomas, and B-cell malignancies, as well as other autoimmune diseases. Research partners include Centocor , Genentech , Eli Lilly , and Human Geonome Sciences . To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Xencor, Inc. Financials
| Company Type | Private Single Location |
| Annual Sales (mil.) | $3.8 |
| Employees | 50 |
Xencor, Inc. Executives
15 executives listed for Xencor, Inc.'s Monrovia, CA location.
| Title | Name & Bio | Contact |
| Chairman | David King | Network |
| President, CEO, and Director | Bassil Dahiyat | Network |
| Senior Director, Finance | John Kuch | Network |
Competition
Competitive Landscape for Xencor, Inc.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Xencor, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
